| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1971164 | Clinical Biochemistry | 2010 | 5 Pages |
Abstract
These results, possible due to a diminished copper content of the circulating ceruloplasmin, suggest that marginal or moderate copper deficiency may have a substantial prevalence among patients treated with valproic acid.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Natalia Lampón, J. Carlos Tutor,